BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9581841)

  • 1. Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
    Hiraguri S; Godfrey T; Nakamura H; Graff J; Collins C; Shayesteh L; Doggett N; Johnson K; Wheelock M; Herman J; Baylin S; Pinkel D; Gray J
    Cancer Res; 1998 May; 58(9):1972-7. PubMed ID: 9581841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors.
    Lombaerts M; Middeldorp JW; van der Weide E; Philippo K; van Wezel T; Smit VT; Cornelisse CJ; Cleton-Jansen AM
    Biochem Biophys Res Commun; 2004 Jun; 319(2):697-704. PubMed ID: 15178462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
    Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
    BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
    Hajra KM; Ji X; Fearon ER
    Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
    Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
    Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic control of E-cadherin (CDH1) by CpG methylation in metastasising laryngeal cancer.
    Azarschab P; Stembalska A; Loncar MB; Pfister M; Sasiadek MM; Blin N
    Oncol Rep; 2003; 10(2):501-3. PubMed ID: 12579297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer.
    Bagadi SA; Prasad CP; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Breast Cancer Res Treat; 2007 Sep; 104(3):277-86. PubMed ID: 17115114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
    Kang H; Mansel RE; Jiang WG
    Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression.
    Oliveira C; Sousa S; Pinheiro H; Karam R; Bordeira-Carriço R; Senz J; Kaurah P; Carvalho J; Pereira R; Gusmão L; Wen X; Cipriano MA; Yokota J; Carneiro F; Huntsman D; Seruca R
    Gastroenterology; 2009 Jun; 136(7):2137-48. PubMed ID: 19269290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
    van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL
    Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1Alpha,25-dihydroxyvitamin D3 induces de novo E-cadherin expression in triple-negative breast cancer cells by CDH1-promoter demethylation.
    Lopes N; Carvalho J; Durães C; Sousa B; Gomes M; Costa JL; Oliveira C; Paredes J; Schmitt F
    Anticancer Res; 2012 Jan; 32(1):249-57. PubMed ID: 22213313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive genetic and functional characterization of IPH-926: a novel CDH1-null tumour cell line from human lobular breast cancer.
    Christgen M; Bruchhardt H; Hadamitzky C; Rudolph C; Steinemann D; Gadzicki D; Hasemeier B; Römermann D; Focken T; Krech T; Ballmaier M; Schlegelberger B; Kreipe H; Lehmann U
    J Pathol; 2009 Apr; 217(5):620-32. PubMed ID: 19191266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
    Jones JL; Shaw JA; Pringle JH; Walker RA
    J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ.
    Horikawa Y; Sugano K; Shigyo M; Yamamoto H; Nakazono M; Fujimoto H; Kanai Y; Hirohashi S; Kakizoe T; Habuchi T; Kato T
    J Urol; 2003 Apr; 169(4):1541-5. PubMed ID: 12629411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer.
    Concolino P; Papa V; Mozzetti S; Ferlini C; Pacelli F; Martinelli E; Ricci R; Filippetti F; Scambia G; Doglietto GB
    J Surg Res; 2004 Sep; 121(1):50-5. PubMed ID: 15313375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.